• One Health
  • Pain Management
  • Oncology
  • Anesthesia
  • Geriatric & Palliative Medicine
  • Ophthalmology
  • Anatomic Pathology
  • Poultry Medicine
  • Infectious Diseases
  • Dermatology
  • Theriogenology
  • Nutrition
  • Animal Welfare
  • Radiology
  • Internal Medicine
  • Small Ruminant
  • Cardiology
  • Dentistry
  • Feline Medicine
  • Soft Tissue Surgery
  • Urology/Nephrology
  • Avian & Exotic
  • Preventive Medicine
  • Anesthesiology & Pain Management
  • Integrative & Holistic Medicine
  • Food Animals
  • Behavior
  • Zoo Medicine
  • Toxicology
  • Orthopedics
  • Emergency & Critical Care
  • Equine Medicine
  • Pharmacology
  • Pediatrics
  • Respiratory Medicine
  • Shelter Medicine
  • Parasitology
  • Clinical Pathology
  • Virtual Care
  • Rehabilitation
  • Epidemiology
  • Fish Medicine
  • Diabetes
  • Livestock
  • Endocrinology

Just Ask the Expert: Intralesional chemotherapy

Article

When do you use intralesional chemotherapy? In what cases might it be useful?

Untitled DocumentDr. Fan welcomes oncology questions from veterinarians and technicians.

E-mail: [email protected]

Subject line: Oncology Questions

Q: When do you use intralesional chemotherapy? In what cases might it be useful?

A: Effective cancer treatment in dogs and cats necessitates the delivery of chemotherapeutic agents at concentrations high enough to cause cancer cell death. As such, the pharmacokinetics and biodistribution of chemotherapeutic agents are crucial factors in treatment outcomes. It has been documented in certain solid tumors that the pressure within the interstitial space (space found between tumor cells) is very high. Elevated intratumoral interstitial pressures would impede the diffusion of systemically administered chemotherapy from the bloodstream into the tumor interstitium. Subsequently, tumor cells would not be exposed to high concentrations of anticancer agents.

The intralesional delivery of chemotherapy is attractive in the sense that one can instill a high concentration of drug into a small confined area. Intralesional delivery thereby maximizes tumor cell exposure to cytotoxic drugs and, it is hoped, enhances anticancer effects. Although intralesional therapy does provide a pharmacokinetic advantage, it also can result in some undesirable effects including 1) drug exposure to the environment and to people as the compound oozes out of the injection site and 2) potential local tissue necrosis secondary to nonspecific direct cytotoxic effects to normal local tissues.

In light of these drawbacks, intralesional chemotherapy is not particularly attractive for most veterinarians. However, some specific instances do exist in which intralesional therapy is effective. One such example would be the injection of corticosteroids (triamcinolone) directly into a cutaneous mast cell tumor. This form of intralesional therapy is well-tolerated and effective in reducing mast cell tumor size, and accidental human exposure to the corticosteroids used would not be a serious problem.

Timothy M. Fan, DVM, PhD, DACVIM (internal medicine and oncology)

Department of Veterinary Clinical Medicine

College of Veterinary Medicine

University of Illinois

Urbana, IL 61802

Related Videos
Image Credit: © Przemyslaw Iciak - stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.